Literature DB >> 7104152

The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease.

W Kupper, C W Hamm, W Bleifeld.   

Abstract

1 The study was designed to elucidate further the mechanism by which beta-adrenoceptor antagonism with pindolol relieves the symptoms of angina pectoris in patients with coronary heart disease. 2 Pindolol administration was associated with an elevated threshold for angina pectoris and improved myocardial lactate metabolism during supraventricular pacing. 3 This beneficial effect of pindolol was independent of changes in myocardial blood flow and was not mediated by haemodynamic effects. 4 The results suggest that in angina pectoris, in addition to the recognized beneficial effects of beta-adrenoceptor blockade, the actions of pindolol also result from, as yet, poorly described phenomena such as redistribution of myocardial blood flow or metabolic effects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104152      PMCID: PMC1402158          DOI: 10.1111/j.1365-2125.1982.tb01932.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.

Authors:  H S Mueller; S M Ayres; A Religa; R G Evans
Journal:  Circulation       Date:  1974-06       Impact factor: 29.690

2.  Measurement of coronary sinus blood flow by continuous thermodilution in man.

Authors:  W Ganz; K Tamura; H S Marcus; R Donoso; S Yoshida; H J Swan
Journal:  Circulation       Date:  1971-08       Impact factor: 29.690

3.  Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.

Authors:  D J Battock; H Alvarez; C A Chidsey
Journal:  Circulation       Date:  1969-02       Impact factor: 29.690

4.  Propranolol in patients with angina pectoris.

Authors:  R E Gianelly; R H Goldman; B Treister; D C Harrison
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

5.  Multicenter trial of propranolol in angina pectoris.

Authors:  R H Grant; P Keelan; R J Kernohan; J C Leonard; L Nancekievill; K Sinclair
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  Effect of propranolol on regional myocardial blood flow in acute ischaemia.

Authors:  B Pitt; P Craven
Journal:  Cardiovasc Res       Date:  1970-04       Impact factor: 10.787

7.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

8.  Cardiovascular pharmacology of propranolol in man.

Authors:  S Wolfson; R Gorlin
Journal:  Circulation       Date:  1969-10       Impact factor: 29.690

9.  Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.

Authors:  W M Kirby; J B De Maine; W S Serrill
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

10.  Glucose extraction by the human myocardium during pacing stress.

Authors:  A S Most; R Gorlin; J S Soeldner
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

View more
  1 in total

1.  Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol.

Authors:  H Ihlen; S Simonsen; D Welzel
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.